Facebook
Twitter
LinkedIn
ForwardPulse - Cutting it Cloze: Clozapine Toxicity in COVID-19
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Pharmacist need to know how to monitor clozapine in patients with COVID-19 infection.
Target Audience
Pharmacist
Learning Objectives
1. Recognize dose-related and titration-related complications of clozapine
2. Describe therapeutic drug monitoring of clozapine
3. Describe how COVID-19 infection may impact clozapine levels
4. Identify dose adjustments for clozapine in the setting of supratherapeutic levels during COVID infection
Additional Information
| Attachment | Size |
|---|---|
 Cutting in Cloze Handout H Ferro May 2022.pdf | 164.22 KB |
 Pulse May 18th.docx | 16.97 KB |
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Pharmacist need to know how to monitor clozapine in patients with COVID-19 infection.
Harrison Ferro, PharmD
PGY1 Pharmacy Resident
UPMC Western Psychiatric Hospital
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.